-The Indian Express Kolkata: As the investigation into the Saradha chit fund scam threatens to reach the doorstep of the Trinamool Congress, the markets watchdog is learnt to have warned of a larger, more frightening scenario: similar Ponzi schemes run by at least five other companies in West Bengal, involving over Rs 4,000 crore of small investors' money. In its latest communication sent to the state government, the Securities and Exchange Board...
More »SEARCH RESULT
With police help, banned Naxal group takes on Maoists in Jharkhand -Deepu Sebastian Edmond
-The Indian Express As coming-of-age rituals go, the Tritiya Sammelan Prastuti Committee (TSPC) couldn't have planned it better. Acting on intelligence by its cadre, it moved in on a group of Maoists in Chatra district's Lawalong Tola on the intervening night of March 27-28, killing 10. Among the dead was Lalesh Yadav, secretary of the Bihar-Jharkhand-North Chhattisgarh Special Area Committee, and his closest subordinates, thus leaving a vacuum at the heart...
More »Reality check: India accounts for one-third of the world poor, says World Bank -Priyadarshi Siddhanta
-The Indian Express Washington: India accounts for one-third of the world poor, people living on less than USD 1.25 (about Rs 65) per day, a World Bank report on poverty has said. The report said that 1.2 billion people still living in extreme poverty across the world. "The State of the Poor: Where are the Poor and Where are the Poorest?," using data released in the latest World Development Indicators, shows that extreme...
More »Remarkable Declines in Global Poverty, But Major Challenges Remain
-The World Bank WASHINGTON: The number of people living on less than $1.25 per day has decreased dramatically in the past three decades, from half the citizens in the developing world in 1981 to 21 percent in 2010, despite a 59 percent increase in the developing world population. However, a new analysis of extreme poverty released today by the World Bank shows that there are still 1.2 billion people living in...
More »Domestic firms rejoicing on Glivec verdict-Sushmi Dey
-The Business Standard Now, local firms can sell their low-priced generic version of the drug in India and export it to developing markets, where it is not patented Domestic drug firms such as Cipla, Natco, Ranbaxy and Hetero are a happier lot following the Supreme Court verdict on Monday, dismissing Novartis AG's patent plea for anti-cancer drug imatinib mesylate or Glivec, as sold by the Swiss drug maker. This is because the judgement...
More »